American Journal on Addictions

Papers
(The median citation count of American Journal on Addictions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information30
Stand against stigma27
AAAP's Annual Meeting and Scientific Symposium27
Self assessment ad (002)24
AAAP 36th Annual Meeting & Scientific Symposium Save the Date23
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort22
Call for Special Issue 202418
2024 Annual Meeting Posters17
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey16
AAAP Stimulant Use Disorder PIP16
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States16
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression15
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances15
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–202113
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada13
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment13
Gender differences in circumstances associated with cannabis use13
A scoping review of sensory‐based interventions to address alcohol consumption13
Issue Information12
AAAP Annual meeting ad12
Become a member of AAAP!11
AM Registration Flyer11
Synthetic cannabinoid use and the acquired preparedness model11
Call for Review Papers 202411
Call for Special Issue Papers 202511
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia11
Narcotics Anonymous members in recovery from methamphetamine use disorder10
Tobacco use and impulsivity in people with mental illness: A systematic review10
Correlates of optimism among patients in substance use disorder inpatient treatment10
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms10
Emotional regulation in Gaming Disorder: A systematic review9
Call for Review Papers 20249
PCSS‐MOUD AND ORN: Find out more about AAAP's national grant initiatives9
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?9
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP9
Call for Special Issue Papers 20249
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study8
Issue Information ‐ ToC7
Issue Information7
Issue Information ‐ Editorial Board7
AJA Annual Meeting 20237
AAAP AATT Preconference7
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population7
Preconference On‐Demand availability7
Call for review papers 20227
Issue Information ‐ Editorial Board7
7
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates6
AAAP Call for Abstracts6
AAAP Podcast EP6
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications5
Stand Against Stigma5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us5
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)5
2023 Advanced Addiction Psychopharmacology Course5
Call for Review Papers 20255
Issue Information ‐ ToC5
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!5
Personality predicting relapse: A facet analysis of the NEO PI‐R5
Health care service utilization and drug overdose death: A national nested case–control registry study5
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study5
Issue Information ‐ Editorial Board5
Extended‐release buprenorphine in pregnancy5
AAAP's Performance in practice activities5
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder5
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States4
Cannabis Use Disorders Performance in Practice4
Association between experiencing gambling problems and adverse behavioral health outcomes among U.S. military service members, 20184
2023 Addictions and Their Treatment Course4
Addiction specialists' attitudes toward psychedelics: A National Survey4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study4
Call for Symposium Abstracts4
4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs4
Call for special issue 20234
Call for Special Issue 20234
AAAP NEWSLETTER: What do your colleagues have to say about the latest updates in Addiction Psychiatry?4
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!4
Call for Special Issue Papers 20254
Medical Update3
Stand Against Stigma3
AAAP 2024 Self‐Assessment Exam Now Available3
AAAP Membership benefits3
Issue Information ‐ Editorial Board3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem3
2021 AJA Reviewer List3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth3
3
AJA AM save the date 20233
Save the Date ‐ Annual Meeting 20253
AJA AM Save the Date 20233
Mini‐Symposia I3
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 20252
Gambling, tobacco use, and health among individuals in substance use disorder treatment2
Psychotherapy Webinar Series AJA2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study2
Educating the community about the opioid epidemic and medications for opioid use disorder2
Daily cannabis use may cause cannabis‐induced hyperalgesia2
The mediating role of impulsivity in the relationship between childhood maltreatment and depression in methamphetamine patients2
Call for special issue 20232
2025 Call for Symposium Abstracts2
Issue Information ‐ Editorial Board2
2
Become an AAAP Member2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders2
Addiction Psychiatry Advanced Psychotherapy Curriculum2
Mini‐Symposia II2
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 20242
AAAP Membership2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients2
Cannabis Use PIP Ad2
Paper sessions2
Concurrent Paper Sessions2
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series2
Trends in substance use disorder diagnoses among Veterans, 2009–20192
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem2
Symposium I2
ORN Advancing racial equity2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic2
Opioid Recover Network ‐ ORN: Recruiting qualified consultants for the ORN2
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review2
Medication Management for Stimulant Use Disorder Webinar2
Call for Review Papers 20232
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort2
Cannabis and the overdose crisis among US adolescents1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use1
AAAP conference agenda1
Program title youth substance use and addiction timely updates on a critical issue1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder1
32nd AAAP Annual meeting & scientific symposium recap1
Conference Schedule1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting1
Call for Special Issue Papers 20261
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
Addiction Psychiatry Advanced Psychotherapy Curriculum1
Call for review papers 20221
Call for special issue 20231
AAAP ORN PIP ad1
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students1
AAAP Pre‐Conference On‐Demand Course ‐ AATT & AAP1
33rd AAAP Annual Meeting and Scientific Symposium Recap1
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis1
AJA Psychedelics1
Issue Information ‐ ToC1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?1
Opioid use disorder in the active service: Implications for intervention1
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center1
Film & Media Workshop1
PCSS exchange AJA Ad1
Symposium III1
Promoter region variant C‐824T in the TH gene modulates the subjective effects of cocaine1
Medical Update1
Issue Information1
AJA Annual Meeting 20241
Call for special issue 20231
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization1
Legalization of cannabis in Canada—Local media analysis1
Examining family member characteristics by treatment status of the relative with substance use problems1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study1
Issue Information1
2023 Advanced Addiction Psychopharmacology Course1
2024 Annual Meeting Posters1
Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study0
AAAP Psychotherapy Curriculum Series0
Become a AAAP Member0
Call for Review Papers 20240
Imposter syndrome and college students' drinking behaviors: The roles of negative affect and coping motivated alcohol use0
AAAP PIPS 20230
Trajectories of prescription opioid and heroin use in adulthood0
FREE WEBINAR: Cultural Considerations in Tribal Behavioral Health Practice, December 10, 20250
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use0
Reasons for electronic cigarette use: Differences based on sex and young adult status0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients0
Call for Special Issue 20220
Correction to “2024 Annual Meeting Posters”0
AAAP Podcast0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review0
Symposia, Medical Update, and Case Conference0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment0
AAAP podcast0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey0
Pain intensity in patients using extended‐release naltrexone or opioid agonists and its effect on extended‐release naltrexone treatment outcomes0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study0
Stand against stigma0
AAAP_Call for Review papers‐20240
Issue Information0
Symposium II0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program0
Issue Information0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 20240
AAAP Performance and Practice (PIP) Resources0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone0
Issue Information ‐ Editorial Board0
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,” Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–4030
Symposium IV0
Double trouble ‐ Examining the co‐occurrence of compulsive sexual behavior disorder and gambling disorder among two American samples0
Issue Information0
AJA psychedelic Ad0
Film & Media Workshop0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths0
Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples0
Medical marijuana access and prolonged opioid use among adolescents and young adults0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial0
Issue Information0
Motivational Interviewing PIP0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial0
Travel Award AJA0
2022 Self‐Assessment examination0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study0
Conference Schedule0
0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance0
Issue Information ‐ Editorial Board0
2024 Reviewer List0
Issue Information0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder0
0
Become a AAAP Member0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder0
Become A AAAP Member!0
CSAM‐SMCA 2022 Scientific conference and annual meeting0
Estimating the effects of prenatal cannabis exposure on birth outcomes0
FREE Training & Mentoring: PCSS and ORN0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience0
Issue Information0
0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?0
Medication treatment for alcohol use disorder in special populations0
Psychotherapy Webinar Series AJA0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder0
2023 Reviewer List (n = 223)0
AAAP Travel Awards Open0
Call for review papers 20230
Issue Information0
Call for review papers 20230
AAAP's Educational Offerings0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20190
0.09118914604187